Francis Patrick Ostronic - Aug 2, 2022 Form 4 Insider Report for Cyclo Therapeutics, Inc. (CYTH)

Role
Director
Signature
/s/ Francis Patrick Ostronic
Stock symbol
CYTH
Transactions as of
Aug 2, 2022
Transactions value $
$0
Form type
4
Date filed
8/4/2022, 04:03 PM
Previous filing
May 23, 2022
Next filing
Sep 22, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYTH Common Stock Award $0 +7.16K +5.17% $0.00 146K Aug 2, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the grant of fully-vested shares of common stock that the Reporting Person elected to receive in lieu of cash compensation under the Issuer's non-employee director compensation policy. Grant reflects director compensation for the second quarter of 2022. The number of shares received in lieu of cash was calculated based on the closing price of 1.92 per share of common stock on August 1, 2022.